Home » Newsletters » BioWorld Science

BioWorld Science

April 28, 1997

View Archived Issues

LifeCell issued U.S. patent for ThromboSol blood platelet preservation product

Antex Biologics allowed patents on adhesin receptor technology and H. influenzae protein

Exactech and the University of Florida Tissue Bank to codevelop biologic bone repair material

Discovery of potent and selective mu-opiate receptor agonists

Schering-Plough and Myriad Genetics enter into strategic collaboration

Sobel to acquire majority interest in Sidmak Laboratories

Matrix initiates phase II trial of IntraDose in liver cancer

Glaxo Wellcome discovers potent BAT inhibitor

Potent, metabolically stable cyclic urea HIV protease inhibitors under development at DuPont Merck

VIMRx completes phase I studies for VIMRxyn

Positive phase III results from Hyal's actinic keratosis trial

Cardiovascular Diagnostics and Lilly enter into development agreement

Novopharm and Glaxo Wellcome reach agreement for ranitidine

Altarex receives funding for photodynamic therapy for ovarian cancer research

Genelabs reports preliminary results from phase III trial of GL-701 for lupus

MedImmune's vaccine candidate prevents urinary tract infections in preclinical studies

Potential new treatments highlighted at recent periodontology symposium

Vascular Therapeutics reports positive safety and efficacy profile for Vasoflux

Emisphere receives notices of allowance for oral delivery technologies

Potent TNF inhibitor described by Celgene

Xoma and Pfizer discontinue U.S. phase III trial of E5

Parke-Davis SAR studies lead to potent, selective D4 antagonist

BioChem Pharma's novel flu vaccine meets phase I trial endpoints

RPR describes novel farnesyltransferase inhibitors

Amarillo Biosciences initiates clinical trial with interferon alfa in bone marrow disorders

Axcan receives IND approval for URSO in hypercholesterolemia

Matrix Pharmaceutical announces marketing partner for AccuSite in Spain and Portugal

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...